Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Extranodal natural killer/T-cell lymphoma involving the gastrointestinal tract: analysis of clinical features and outcomes from the Asia Lymphoma Study Group.

Kim SJ, Jung HA, Chuang SS, Hong H, Guo CC, Cao J, Hong XN, Suzuki R, Kang HJ, Won JH, Chng WJ, Kwong YL, Suh C, Song YQ, Zhu J, Tay K, Lim ST, Suzumiya J, Lin TY, Kim WS; Asia Lymphoma Study Group.

J Hematol Oncol. 2013 Nov 16;6:86. doi: 10.1186/1756-8722-6-86.

2.

Cutaneous extranodal natural killer/T-cell lymphoma: a comparative clinicohistopathologic and survival outcome analysis of 45 cases according to the primary tumor site.

Lee WJ, Jung JM, Won CH, Chang SE, Choi JH, Chan Moon K, Park CS, Huh J, Lee MW.

J Am Acad Dermatol. 2014 Jun;70(6):1002-9. doi: 10.1016/j.jaad.2013.12.023. Epub 2014 Mar 12.

PMID:
24629518
3.

Prognostic characteristics of gastrointestinal tract NK/T-cell lymphoma: an analysis of 47 patients in China.

Jiang M, Chen X, Yi Z, Zhang X, Zhang B, Luo F, Jiang Y, Zou L.

J Clin Gastroenterol. 2013 Sep;47(8):e74-9. doi: 10.1097/MCG.0b013e31829e444f.

PMID:
23948755
4.

CD56-negative extranodal NK/T cell lymphoma should be regarded as a distinct subtype with poor prognosis.

Wang L, Wang Z, Xia ZJ, Lu Y, Huang HQ, Zhang YJ.

Tumour Biol. 2015 Sep;36(10):7717-23. doi: 10.1007/s13277-015-3485-0. Epub 2015 May 3.

PMID:
25935537
5.

First-line combination of gemcitabine, oxaliplatin, and L-asparaginase (GELOX) followed by involved-field radiation therapy for patients with stage IE/IIE extranodal natural killer/T-cell lymphoma.

Wang L, Wang ZH, Chen XQ, Li YJ, Wang KF, Xia YF, Xia ZJ.

Cancer. 2013 Jan 15;119(2):348-55. doi: 10.1002/cncr.27752. Epub 2012 Jul 18.

6.

Prognostic impact of beta-2 microglobulin in patients with extranodal natural killer/T cell lymphoma.

Yoo C, Yoon DH, Jo JC, Yoon S, Kim S, Lee BJ, Huh J, Lee SW, Suh C.

Ann Hematol. 2014 Jun;93(6):995-1000. doi: 10.1007/s00277-014-2015-2. Epub 2014 Jan 19.

PMID:
24441948
7.

Extranodal natural killer/T-Cell lymphoma: A population-based comparison of sinonasal and extranasal disease.

Vazquez A, Khan MN, Blake DM, Sanghvi S, Baredes S, Eloy JA.

Laryngoscope. 2014 Apr;124(4):888-95. doi: 10.1002/lary.24371. Epub 2013 Oct 7.

PMID:
24114591
8.

Clinicopathological study of pulmonary extranodal nature killer/T-cell lymphoma, nasal type and literature review.

Ding W, Wang J, Zhao S, Yang Q, Sun H, Yan J, Gao L, Yao W, Zhang W, Liu W.

Pathol Res Pract. 2015 Jul;211(7):544-9. doi: 10.1016/j.prp.2015.04.002. Epub 2015 Apr 17. Review.

PMID:
25953340
9.

Combined modality treatment for primary gastrointestinal non-Hodgkin's lymphoma: the Milan Cancer Institute experience.

Tondini C, Giardini R, Bozzetti F, Valagussa P, Santoro A, Bertulli R, Balzarotti M, Rocca A, Lombardi F, Ferreri AJ, et al.

Ann Oncol. 1993 Dec;4(10):831-7.

PMID:
8117602
10.
11.

The clinical study of extranodal natural killer cell lymphoma, nasal type.

Gui W, Zhao Z, Shen Q, Wang T, Yang B, He J, Li X, Hou S, Zhang L, Zhang Q, Su L.

Med Oncol. 2011 Dec;28 Suppl 1:S367-72. doi: 10.1007/s12032-010-9756-0. Epub 2010 Dec 3.

PMID:
21128014
12.

Prognostic significance of Ki-67 antigen expression in extranodal natural killer/T-cell lymphoma, nasal type.

Jiang L, Li P, Wang H, Liu J, Zhang X, Qiu H, Zhang B.

Med Oncol. 2014 Oct;31(10):218. doi: 10.1007/s12032-014-0218-y. Epub 2014 Sep 10.

PMID:
25204411
13.

Diagnosis and management of rare gastrointestinal lymphomas.

Hawkes EA, Wotherspoon A, Cunningham D.

Leuk Lymphoma. 2012 Dec;53(12):2341-50. doi: 10.3109/10428194.2012.695780. Epub 2012 Jun 21. Review.

PMID:
22616672
14.

NK and NK-like T-cell lymphoma in extranasal sites: a comparative clinicopathological study according to site and EBV status.

Ko YH, Cho EY, Kim JE, Lee SS, Huh JR, Chang HK, Yang WI, Kim CW, Kim SW, Ree HJ.

Histopathology. 2004 May;44(5):480-9.

PMID:
15139996
15.

Fasting blood glucose is a novel prognostic indicator for extranodal natural killer/T-cell lymphoma, nasal type.

Cai Q, Luo X, Liang Y, Rao H, Fang X, Jiang W, Lin T, Lin T, Huang H.

Br J Cancer. 2013 Feb 5;108(2):380-6. doi: 10.1038/bjc.2012.566. Epub 2013 Jan 8.

16.

A comparative population-based analysis of sinonasal diffuse large B-cell and extranodal NK/T-cell lymphomas.

Dubal PM, Dutta R, Vazquez A, Patel TD, Baredes S, Eloy JA.

Laryngoscope. 2015 May;125(5):1077-83. doi: 10.1002/lary.25111. Epub 2014 Dec 27.

PMID:
25546466
17.

Tumor cell nuclear diameter and CD30 expression as potential prognostic parameter in patients with extranodal NK/T-cell lymphoma, nasal type.

Hong J, Park S, Baek HL, Jung JH, Kang IG, Sym SJ, Park J, Ahn JY, Cho EK, Kim ST, Shin DB, Lee JH.

Int J Clin Exp Pathol. 2012;5(9):939-47. Epub 2012 Oct 20.

18.

[Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].

Zou GR, Zhang YJ, Xie FY, Zheng W, Li HX, Xia YF, Lin TY, Lu TX.

Ai Zheng. 2006 Dec;25(12):1543-9. Chinese.

PMID:
17166383
19.

Both c-Myc and Ki-67 expression are predictive markers in patients with extranodal NK/T-cell lymphoma, nasal type: a retrospective study in China.

Huang X, Sun Q, Fu H, Zhou X, Guan X, Wang J.

Pathol Res Pract. 2014 Jun;210(6):351-6. doi: 10.1016/j.prp.2014.02.004. Epub 2014 Feb 23.

PMID:
24642368
20.

Clinical Outcomes and Prognostic Factors of Up-Front Autologous Stem Cell Transplantation in Patients with Extranodal Natural Killer/T Cell Lymphoma.

Yhim HY, Kim JS, Mun YC, Moon JH, Chae YS, Park Y, Jo JC, Kim SJ, Yoon DH, Cheong JW, Kwak JY, Lee JJ, Kim WS, Suh C, Yang DH; Consortium for Improving Survival of Lymphoma Study.

Biol Blood Marrow Transplant. 2015 Sep;21(9):1597-604. doi: 10.1016/j.bbmt.2015.05.003. Epub 2015 May 8.

Items per page

Supplemental Content

Write to the Help Desk